1E Therapeutics
1E Therapeutics

1E Therapeutics

Measured by AhrefsDR21Ahrefs DR: 21/100. Below median. Measured by Ahrefs. Median 44.Measured by StartupHub.aiAgent32Agent Readiness: 32/100. Below median. Measured by StartupHub.ai. Median 41.Measured by Google PageSpeedSpeed77Site Speed: 77/100. Top 25%. Measured by Google PageSpeed. Median 62.Measured by StartupHub.aiTrust61Data Trust: 61/100. Above median. Measured by StartupHub.ai. Median 61.

Drug development company creating first-in-class RNA-targeting therapeutics using a proprietary platform.

Website

About this profileCompany details: from public sourcesFunding: no announced round on fileOwnership: not yet claimed by the companyScores: measured by named tools; each links to its methodOur rules

2020Active49

About

1E Therapeutics is a drug development company creating a novel class of programmable oligonucleotide therapeutics. Their patented platform autonomously and precisely silences disease-causing RNAs to treat intractable diseases, including genetically driven, infectious, and chronic conditions. This approach aims to deliver safer and more targeted therapies for a wide array of indications.

Competitors & Alternatives (6)

Similar companies

M
Moderna
Moderna

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Shares Life Sciences, Biotech

AB
Adaptive Biotechnologies
Adaptive Biotechnologies

Leveraging the adaptive immune system to diagnose and treat disease.

Shares Biotech, HealthTech

I
Immunai
Immunai

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Shares Drug Development, Life Sciences

C
CytoReason
CytoReason

Develops a computational model of the human body for drug discovery and development.

Shares Drug Discovery, Drug Development

B
Benchling
Benchling

R&D cloud platform for life sciences, enabling scientific innovation and productivity.

Shares Biotech, HealthTech

MB
Manifold Bio
Manifold Bio

AI-guided drug discovery platform for tissue-targeted medicines.

Shares Biotech, Drug Discovery

Key facts

Website
1etx.com
Founded
2020
Employees
49
Total funding
$120M (Seed)
Business model
B2B

Funding rounds

Funding rounds raised by 1E Therapeutics
DateRoundAmountLead investors
8 Dec 2021Seed$120M

Tech stack

Detected on 1etx.com, last scanned 3 Nov 2026.

Frontend
jQuery
CMS / Builders
WordPress
CDN
Cloudflare
Email provider
Microsoft 365
Run your own scan

1E Therapeutics scores 21. Does yours?

That is its Ahrefs DR: the backlink strength of a domain, on the Ahrefs 0 to 100 scale. Paste your website and you get yours in about a minute.

Add first review

Frequently asked

Is 1E Therapeutics trustworthy and reputable?

StartupHub's Data Trust & Reputation score for 1E Therapeutics is 61 out of 100, a generally safe rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.

How much funding has 1E Therapeutics raised?

1E Therapeutics has raised a total of $120M in funding. The most recent round on record is Seed.

How many employees does 1E Therapeutics have?

1E Therapeutics has approximately 49 people on record.

Public record

SEC filings, insider activity, nonprofit links and pay benchmarks for 1E Therapeutics